LAS VEGAS—The lack of a single gold standard test for inflammatory bowel disease contributes to misdiagnosis of other gastrointestinal conditions with overlapping symptoms, subjecting patients to unnecessary therapies and potential harm. A new study exploring so-called “IBD mimics” has shed some light on this tricky diagnostic territory.
The research examined a sample of perplexing case studies in which IBD was initially suspected but ultimately ruled out. Findings from the